Calcium and Phosphorus in Chronic Renal Failure during Nutritional Therapy1

Author(s):  
Mackenzie Walser ◽  
William E. Mitch ◽  
Virginia U. Collier
2012 ◽  
Vol 87 (5) ◽  
pp. 752-755 ◽  
Author(s):  
Eduardo Vinicius Mendes Roncada ◽  
Marilda Aparecida Milanez Morgado de Abreu ◽  
Mayra Falcão Pereira ◽  
Claúdia Cardoso Macedo de Oliveira ◽  
Gisele Alborghetti Nai ◽  
...  

Calciphylaxis, also known as calcific uremic arteriolopathy, is a severe complication often observed in patients with hyperparathyroidism secondary to chronic renal failure, which occurs mainly in women. It is characterized by ischemic tissue loss secondary to progressive vascular compromise. This is a rare and severe condition and its pathogenesis is unclear. The best treatment is prevention, especially in order to maintain adequate levels of calcium and phosphorus. We describe a case of this disease in a patient with hyperparathyroidism secondary to chronic renal failure who underwent medical treatment, surgical debridement and total skin autografts, with resolution of symptoms after 6 months.


Author(s):  
Edward C. Rosenow

• Patient was poorly compliant with dialysis • Mild dyspnea on exertion • Infiltrate in the lungs occurs when calcium and phosphorus are not maintained at normal levels in chronic renal failure • Also occurs when patient is poorly compliant with dialysis


Sign in / Sign up

Export Citation Format

Share Document